Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 14,975	$ 9,860
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	4,032	4,757
Amortization of debt discount	0	2,503
Amortization of deferred debt issuance costs	880	1,058
Amortization	12,799	13,519
Stock-based compensation	4,463	3,387
Deferred income taxes	177	(2,688)
Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable	(163)	11,957
Inventories	(21,857)	(11,638)
Accounts payable	9,205	2,804
Accrued compensation and benefits	(14,966)	(8,955)
Other assets	(6,129)	(6,002)
Other liabilities	(3,088)	1,782
Net cash provided by operating activities	328	22,344
Cash flows from investing activities:
Purchases of property, plant and equipment	(3,687)	(3,109)
Net cash used in investing activities	(3,687)	(3,109)
Cash flows from financing activities:
Payments on term loan	(2,981)	(3,313)
Payments on revolving line of credit	(99,000)	(72,000)
Proceeds from revolving line of credit	110,000	64,000
Payments related to contingent consideration	(798)	0
Dividends paid on common stock	(5,874)	(5,775)
Other, net	6,142	8,216
Net cash provided by (used in) financing activities	7,489	(8,872)
Effect of exchange rate changes on cash and cash equivalents	(113)	(950)
Net increase in cash and cash equivalents	4,017	9,413
Cash and cash equivalents at beginning of period	20,847	27,356
Cash and cash equivalents at end of period	24,864	36,769
Non-cash investing and financing activities:
Dividends payable	$ 5,899	$ 5,813